Elawyers Elawyers
Ohio| Change

United States v. Osbaldo Sarabia, 17-10235 (2019)

Court: Court of Appeals for the Ninth Circuit Number: 17-10235
Filed: Apr. 24, 2019
Latest Update: Mar. 03, 2020
Summary: NOT FOR PUBLICATION FILED UNITED STATES COURT OF APPEALS APR 24 2019 MOLLY C. DWYER, CLERK U.S. COURT OF APPEALS FOR THE NINTH CIRCUIT UNITED STATES OF AMERICA, No. 17-10235 Plaintiff-Appellant, D.C. No. 2:06-cr-00464-JAM-AC-1 v. OSBALDO OSWALDO SARABIA, MEMORANDUM * Defendant-Appellee. Appeal from the United States District Court for the Eastern District of California John A. Mendez, District Judge, Presiding Argued and Submitted September 7, 2018 San Francisco, California Before: BERZON and FR
More
                           NOT FOR PUBLICATION                            FILED
                    UNITED STATES COURT OF APPEALS                        APR 24 2019
                                                                      MOLLY C. DWYER, CLERK
                                                                       U.S. COURT OF APPEALS
                           FOR THE NINTH CIRCUIT

UNITED STATES OF AMERICA,                       No.    17-10235

                Plaintiff-Appellant,            D.C. No.
                                                2:06-cr-00464-JAM-AC-1
 v.

OSBALDO OSWALDO SARABIA,                        MEMORANDUM *

                Defendant-Appellee.

                   Appeal from the United States District Court
                       for the Eastern District of California
                    John A. Mendez, District Judge, Presiding

                     Argued and Submitted September 7, 2018
                            San Francisco, California

Before: BERZON and FRIEDLAND, Circuit Judges, and CARDONE,** District
Judge.

       The government appeals the district court’s grant of a 18 U.S.C.

§ 3582(c)(2) sentence reduction. The government contends that the uncontested

drug quantities in Osbaldo Oswaldo Sarabia’s court-adopted presentence



      *
             This disposition is not appropriate for publication and is not precedent
except as provided by Ninth Circuit Rule 36-3.
      **
            The Honorable Kathleen Cardone, United States District Judge for the
Western District of Texas, sitting by designation.
investigation report (“PSR”) are binding drug quantity findings that render him

ineligible for a sentence reduction. Although the drug quantities in Sarabia’s PSR

are nonbinding, we reverse the grant of sentence reduction because Sarabia’s

specific admissions of drug quantity in his plea agreement render him ineligible.

      Sarabia pleaded guilty to three counts of possession of drugs with intent to

distribute, in violation of 21 U.S.C. § 841(a)(1). He was sentenced to 210 months

imprisonment. After the U.S. Sentencing Commission promulgated Amendment

782, reducing the base offense level for most drugs and quantities by two levels,

Sarabia filed a motion for a 18 U.S.C. § 3582(c)(2) sentence reduction. The district

court granted his motion, concluding that he was eligible for sentence reduction

because no specific finding of drug quantity had been made at the original

sentencing. His sentence was reduced to 168 months imprisonment.

      To determine whether a defendant is entitled to sentence reduction, the

district court applies a two-step inquiry. See United States v. Rodriguez, No. 17-

10233, slip op. at 5 (9th Cir. Apr. 24, 2019). The first step, the only one relevant

here, requires the court to determine whether the amendment to the U.S.

Sentencing Guidelines has the “effect of lowering the defendant’s applicable

[G]uideline[s] range.” U.S. Sentencing Guidelines Manual § 1B1.10(a)(2)(B). This

step necessarily requires a finding of the drug quantity attributable to the defendant

for purposes of determining whether “the defendant is more likely than not


                                           2
responsible for the new quantity threshold under the retroactive Guidelines

amendment.” United States v. Mercado-Moreno, 
869 F.3d 942
, 957 (9th Cir.

2017). A drug quantity is binding at the first step where (1) “the sentencing court

made a specific finding regarding the total quantity of drugs for which the

defendant was responsible,” or (2) “the defendant admitted to a specific total

quantity.” 
Id. (emphases added).
      The government argues that the drug quantity finding in Sarabia’s PSR—

342,527 kilograms of (converted) marijuana—is binding in § 3582(c)(2)

proceedings and renders Sarabia ineligible for sentence reduction. Contrary to the

government’s argument, uncontested drug amounts in a court-adopted PSR are not

binding, specific findings of drug quantity, as they do not fall under either of the

two permitted circumstances. Id.; Rodriguez, slip op. at 15, 18.

      Although the drug quantities in Sarabia’s PSR are nonbinding, Sarabia’s

specific admissions of drug quantity in his plea agreement are binding. Sarabia

specifically admitted to possessing four pounds (or 1.8 kilograms) of

methamphetamine in his vehicle, and 6.25 kilograms of cocaine and 116 pounds

(or 52.6 kilograms) of methamphetamine in his residence. These drug quantity

amounts render him ineligible for sentence reduction, as the 52.6 kilograms of

methamphetamine alone surpasses the new drug quantity threshold under

Amendment 782 for methamphetamine mixture or actual methamphetamine. See


                                          3
U.S.S.G. § 2D1.1(c). We therefore reverse the district court’s grant of a sentence

reduction.

      REVERSED.




                                         4

Source:  CourtListener

Can't find what you're looking for?

Post a free question on our public forum.
Ask a Question
Search for lawyers by practice areas.
Find a Lawyer